Drug name - Signifor

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8299209 RECORDATI RARE Pharmaceutical composition comprising cyclic somatostatin analogues
Dec, 2025

(3 years from now)

US7473761 RECORDATI RARE Somatostatin analogues
Dec, 2026

(4 years from now)

Drugs and Companies using PASIREOTIDE DIASPARTATE ingredient

Market Authorisation Date: 14 December, 2012

Treatment: NA

Dosage: SOLUTION;SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
EQ 0.3MG BASE/ML (EQ 0.3MG BASE/ML) SOLUTION;SUBCUTANEOUS Prescription
EQ 0.6MG BASE/ML (EQ 0.6MG BASE/ML) SOLUTION;SUBCUTANEOUS Prescription
EQ 0.9MG BASE/ML (EQ 0.9MG BASE/ML) SOLUTION;SUBCUTANEOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.